EP1888618A4 - Analogs of glycyl-prolyl-glutamate - Google Patents
Analogs of glycyl-prolyl-glutamateInfo
- Publication number
- EP1888618A4 EP1888618A4 EP06770950A EP06770950A EP1888618A4 EP 1888618 A4 EP1888618 A4 EP 1888618A4 EP 06770950 A EP06770950 A EP 06770950A EP 06770950 A EP06770950 A EP 06770950A EP 1888618 A4 EP1888618 A4 EP 1888618A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- glycyl
- prolyl
- glutamate
- analogs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68381305P | 2005-05-23 | 2005-05-23 | |
PCT/US2006/019909 WO2006127702A2 (en) | 2005-05-23 | 2006-05-23 | Analogs of glycyl-prolyl-glutamate |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1888618A2 EP1888618A2 (en) | 2008-02-20 |
EP1888618A4 true EP1888618A4 (en) | 2009-07-15 |
Family
ID=37452742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06770950A Withdrawn EP1888618A4 (en) | 2005-05-23 | 2006-05-23 | Analogs of glycyl-prolyl-glutamate |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1888618A4 (en) |
JP (1) | JP2008545697A (en) |
WO (1) | WO2006127702A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007106555A2 (en) * | 2006-03-14 | 2007-09-20 | Neuren Pharmaceuticals Limited | Oral formulations of glycyl-2-methylprolyl-glutamate |
EP2170312A1 (en) * | 2007-07-06 | 2010-04-07 | University Of Zurich | Method of preventing and treating acute brain pathologies |
JP2010539067A (en) * | 2007-09-11 | 2010-12-16 | モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト | Use of Gly-Pro-Glu-OH (GPE) as a therapeutic agent |
KR20100056509A (en) | 2007-09-11 | 2010-05-27 | 몬도바이오테크 래보래토리즈 아게 | Use of a peptide as a therapeutic agent |
AU2012208693B2 (en) * | 2011-01-19 | 2015-02-26 | Galapagos Nv | Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases |
HUE036637T2 (en) * | 2011-01-27 | 2018-07-30 | Neuren Pharmaceuticals Ltd | Treatment of autism spectrum disorders using glycyl-l-2-methylprolyl-l-glutamic acid |
SG187271A1 (en) * | 2011-07-07 | 2013-02-28 | Agency Science Tech & Res | Anti-amyloidogenic, alpha-helix breaking ultra-small peptide therapeutic |
JP2016506380A (en) * | 2012-11-28 | 2016-03-03 | ニューレン ファーマシューティカルズ リミテッド | Treatment of autism spectrum disorder using glycyl-L-2-methylprolyl-L-glutamic acid |
CN103275106B (en) * | 2013-04-19 | 2015-09-30 | 暨南大学 | A kind of indole alkaloid adduct and preparation method thereof and preparing the application in antitumor drug |
JOP20220027A1 (en) * | 2019-08-05 | 2023-01-30 | Neuren Pharmaceuticals Ltd | Compositions of trofinetide |
GB202102709D0 (en) * | 2021-02-25 | 2021-04-14 | Univ Southampton | Compounds |
CN113135983B (en) * | 2021-04-12 | 2022-06-24 | 四川大学华西医院 | Antitumor compound and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002094856A2 (en) * | 2001-05-24 | 2002-11-28 | Neuronz Limited | Gpe analogs and peptidomimetics |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6187906B1 (en) * | 1997-08-11 | 2001-02-13 | Aukland Uniservices Limited | Methods to improve neural outcome |
-
2006
- 2006-05-23 WO PCT/US2006/019909 patent/WO2006127702A2/en active Application Filing
- 2006-05-23 EP EP06770950A patent/EP1888618A4/en not_active Withdrawn
- 2006-05-23 JP JP2008513622A patent/JP2008545697A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002094856A2 (en) * | 2001-05-24 | 2002-11-28 | Neuronz Limited | Gpe analogs and peptidomimetics |
Non-Patent Citations (9)
Title |
---|
ALONSO DE DIEGO S A ET AL: "Analogues of the neuroprotective tripeptide Gly-Pro-Glu (GPE): synthesis and structure-activity relationships", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 15, no. 9, 2 May 2005 (2005-05-02), pages 2279 - 2283, XP025313633, ISSN: 0960-894X, [retrieved on 20050502] * |
ALONSO DE DIEGO S A ET AL: "The neuroprotective activity of GPE tripeptide analogues does not correlate with glutamate receptor binding affinity", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 16, no. 13, 1 July 2006 (2006-07-01), pages 3396 - 3400, XP025107379, ISSN: 0960-894X, [retrieved on 20060701] * |
BRIMBLE MARGARET A ET AL: "Synthesis and pharmacological evaluation of side chain modified glutamic acid analogues of the neuroprotective agent glycyl-L-prolyl-L-glutamic acid (GPE).", BIOORGANIC & MEDICINAL CHEMISTRY 17 JAN 2005, vol. 13, no. 2, 17 January 2005 (2005-01-17), pages 519 - 532, XP002528279, ISSN: 0968-0896 * |
GILLESSEN D ET AL: "[Syntheses of thyrotropin-releasing hormones (TRH) (Schaf) and related peptides]", HELVETICA CHIMICA ACTA 1970, vol. 53, no. 1, 1970, pages 63 - 72, XP002528278, ISSN: 0018-019X * |
LAI MICHELLE Y H ET AL: "Synthesis and pharmacological evaluation of glycine-modified analogues of the neuroprotective agent glycyl-L-prolyl-L-glutamic acid (GPE).", BIOORGANIC & MEDICINAL CHEMISTRY 17 JAN 2005, vol. 13, no. 2, 17 January 2005 (2005-01-17), pages 533 - 548, XP002528274, ISSN: 0968-0896 * |
MAEHASHI K ET AL: "Isolation of peptides from an enzymatic hydrolysate of food proteins and characterization of their taste properties.", BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY MAR 1999, vol. 63, no. 3, March 1999 (1999-03-01), pages 555 - 559, XP002528276, ISSN: 0916-8451 * |
PARK JUNG-NIM ET AL: "Taste effects of oligopeptides in a Vietnamese fish sauce", FISHERIES SCIENCE (TOKYO), vol. 68, no. 4, August 2002 (2002-08-01), pages 921 - 928, XP002528277, ISSN: 0919-9268 * |
SLOOTSTRA J W ET AL: "STRUCTURAL ASPECTS OF ANTIBODY-ANTIGEN INTERACTION REVEALED THROUGH SMALL RANDOM PEPTIDE LIBRARIES", MOLECULAR DIVERSITY, ESCOM SCIENCE PUBLISHERS, LEIDEN, NL, vol. 1, no. 2, 1 January 1995 (1995-01-01), pages 87 - 96, XP008065429, ISSN: 1381-1991 * |
TROTTER NICHOLAS S ET AL: "Synthesis and neuroprotective activity of analogues of glycyl-L-prolyl-L-glutamic acid (GPE) modified at the alpha-carboxylic acid.", BIOORGANIC & MEDICINAL CHEMISTRY 17 JAN 2005, vol. 13, no. 2, 17 January 2005 (2005-01-17), pages 501 - 517, XP002528275, ISSN: 0968-0896 * |
Also Published As
Publication number | Publication date |
---|---|
EP1888618A2 (en) | 2008-02-20 |
WO2006127702A3 (en) | 2007-06-14 |
WO2006127702A2 (en) | 2006-11-30 |
JP2008545697A (en) | 2008-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200700357B (en) | Tetrapetide analogs | |
EP1928489A4 (en) | Analogs of ghrelin | |
EP1888618A4 (en) | Analogs of glycyl-prolyl-glutamate | |
MY145179A (en) | Use of tetrahydrobenzoxazines as stabilizers | |
EP2034838A4 (en) | Novel compounds | |
EP2032142A4 (en) | Novel compounds | |
HK1161122A1 (en) | Use of 24-norudca 24-norudca | |
SI2497780T1 (en) | TDF-related compounds and analogs thereof | |
EP1981596A4 (en) | Novel compounds | |
ZA200710861B (en) | Uses of prostacyclin analogs | |
EP1981900A4 (en) | Novel compounds | |
EP1931370A4 (en) | Use of des-aspartate-angiotensin i | |
EP2031965A4 (en) | Novel compounds | |
GB0600483D0 (en) | Novel compounds | |
GB0609252D0 (en) | Novel sytoprotective compounds | |
GB0510013D0 (en) | Interaction of SNEV | |
TWM291236U (en) | Improved structure of bookrack | |
TWM292330U (en) | Improvement of bed-chair structure | |
GB0512574D0 (en) | Uses of (s)-clenbuterol | |
IL166318A0 (en) | Cortiutuo shape of sigu | |
PT1899354E (en) | Synthesis of deoxybiotinyl hexamethylenediamine-dota | |
TWM291302U (en) | Improvement of mask structure | |
TWM291301U (en) | Improvement of mask structure | |
HUP0500461A3 (en) | Pyperazine derivatives of alkyl-oxindoles | |
TWM311768U (en) | Improved structure of A-ladder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20071206 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 25/00 20060101ALI20090602BHEP Ipc: A61P 27/00 20060101ALI20090602BHEP Ipc: A61P 29/00 20060101ALI20090602BHEP Ipc: C07K 5/08 20060101AFI20071220BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090615 |
|
17Q | First examination report despatched |
Effective date: 20091117 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100528 |